Fatty Liver Cirrhosis

Union Minister of Science and Technology launches the Indo-French Liver and Metabolic Disease Network to find India-specific interventions for metabolic disorders

Pre-clinical trials show no evidence of side effects in the product, which is the ninth such to be developed from marine organisms by Kochi-based CMFRI

The family members of NAFLD-cirrhosis patients were 12.5 times more likely to have liver fibrosis